CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL).Part 2: Cohort Expansion. The...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 25 other locations
This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...
Phase 1, Phase 2
Indianapolis, Indiana, United States of America and 19 other locations
Phase 1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non- ...
Phase 1
Indianapolis, Indiana, United States and 8 other locations
participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, transformed folli...
Phase 3
Noblesville, Indiana, United States and 72 other locations
The purpose of this single-arm, open-label, Phase 1b/2a, multicenter basket study is to evaluate whether tafasitamab and parsaclisib can be safely co...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 49 other locations
is in comparison with the combination of rituximab and chemotherapy, the current standard of care treatment approved for Non-Hodgkin...
Phase 3
Indianapolis, Indiana, United States and 75 other locations
is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....
Phase 3
Noblesville, Indiana, United States and 65 other locations
The purpose of this study is to determine the side effects of treatment of the combination of nivolumab and daratumumab in participants with relapsed...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 42 other locations
is focused on participants with previously untreated follicular lymphoma in Part 2, as well as participants with lymphoma that has -...
Phase 3
Noblesville, Indiana, United States and 34 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...
Phase 2
Indianapolis, Indiana, United States and 50 other locations
Clinical trials
Research sites
Resources
Legal